M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
FDA approves Roche's Susvimo for diabetic retinopathy
* Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months
* Susvimo's innovative technology via the Port Delivery Platform may offer an alternative to regular eye injections in the...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search